Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND for clinical trials of siroquine for newly diagnosed GBM

Aug. 23, 2021

Bavarian Nordic studies ABNCoV2 as COVID-19 booster vaccine in phase II

Aug. 23, 2021

ACMT reports on patients becoming ill from use of ivermectin for COVID-19

Aug. 23, 2021

AAV gene therapy targeting CaMKII protects retinal ganglion cells, preserves vision

Aug. 23, 2021

Improved serum metabolic profile and symptoms in patients with ALS treated with ILB

Aug. 23, 2021

Salicylanilide compounds show promise for treating COVID-19

Aug. 23, 2021

APP gene mutation causes autosomal dominant Alzheimer's disease

Aug. 23, 2021

KIN-001 for COVID-19 shows preclinical antiviral, anti-inflammatory and antifibrotic activity

Aug. 23, 2021

Shanghai Bowei Biological Technology, collaborators divulge polynucleotides for expressing HPV 51L1

Aug. 23, 2021

New SREBP inhibitors identified at Capulus Therapeutics

Aug. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...